Kynam Capital Management, LP is 10% Owner at 2seventy bio, Inc. (TSVT). They have made 1 open-market trade across 1 company since 2023, most recently 2023-08-10.
CIK 0001907884
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $515K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TSVT | 5,142,111 | $25.7M |
Shares reported on the most recent Form 4, priced at the 2023-08-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TSVT | BUY | 2023-08-10 | 2023-08-14 | $5.96 | $515K | -15.2% | -41.6% | -65.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.